Entellus Medical Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Entellus Medical (ENTL) Tops Q2 EPS by 5c, Offers Q3 & FY Guidance
August 6, 2015 5:03 PM EDTEntellus Medical (NASDAQ: ENTL) reported Q2 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15 million.
Entellus Medical sees FY2015 EPS of ($0.80)-($1.10), versus the consensus of ($0.98). Entellus Medical sees FY2015... More
